Follow-The-Filings

Security

Apogee Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners 3 new max 0.1% (Dmitry Balyasny - Balyasn...)

owners 9
max % 0.1%
tracked value $332M
qoq N 3 A 2 R 3

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.1% New 0.1% 438,654 $37M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 598,902 $50M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.01 pp 105,241 $8M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 80,201 $7M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 2,857,824 $216M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 92,592 $8M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 58,835 $5M hist
Ron Baron - Bamco Inc. /NY/ (Baron Capital) 2026 Q1 0.0% New 0.0% 15,000 $1M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% New 0.0% 8,027 $676 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$83.98M -$182.15M -$255.84M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $398.41M $529.71M $741.36M
Total non-current assets * $3M $224.24M $195.78M
Total assets $401.4M $753.95M $937.13M
Total current liabilities $20.56M $28.56M $27.91M
Total non-current liabilities * $933,000 $8.6M $5.34M
Total equity $379.91M $716.79M $903.88M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$74.76M -$171.17M -$227.45M
Cash from investing -$273.91M -$300.46M -$179.57M
Cash from financing $315.39M $495.11M $396.49M
Net change in cash -$33.28M $23.47M -$10.53M

ownership over time

filing count by report period · click a bar for that quarter’s holders